알레르기비염 마우스 모델의 이론과 실제
Principles and Application of Mouse Model of Allergic Rhinitis
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Allergic rhinitis is a one of the most prevalent disease and its prevalence has been increasing these days. Many researchers have used the mouse models to study the mechanism of allergic rhinitis and development of anti-allergic medications. In the fields of allergic disease, several models such as allergic asthma, allergic contact dermatitis, and allergic rhinitis etc are introduced and several modifications are used. In case of mouse models of allergic rhinitis, it has been developed and modified from allergic asthma model. Most commonly used allergic rhinitis models are acute models and chronic models are used less. Ovalbumin, house dust mite and fungus are most commonly used allergens. Usually, mouse are sensitized with allergen and adjuvant such as aluminum hydroxide gel or Freund adjuvant for 2-3 weeks (once/week) then are challenged with allergen intranasally every day for 1 week. Mouse are sacrificed within 24 hours after final challenge and several parameters of allergic rhinitis are evaluated. They include nasal rubbing and sneezing count, eosinophil count in the nasal mucosa, total and allergen specific immunoglobulin E, nasal cytokine level and splenic cytokine level by splenocyte culture. By revealing those parameters, researchers could identify the allergic status of the mouse. However, there are many variables in mouse model of allergic rhinitis such as mouse strain, type of allergen, sensitization time, adjuvant, acute or chronic type, and allergen administration route etc. In this review, several variables and protocols of mouse model of AR will be discussed in detail.
Abstract
Allergic rhinitis is a one of the most prevalent disease and its prevalence has been increasing these days. Many researchers have used the mouse models to study the mechanism of allergic rhinitis and development of anti-allergic medications. In the fields of allergic disease, several models such as allergic asthma, allergic contact dermatitis, and allergic rhinitis etc are introduced and several modifications are used. In case of mouse models of allergic rhinitis, it has been developed and modified from allergic asthma model. Most commonly used allergic rhinitis models are acute models and chronic models are used less. Ovalbumin, house dust mite and fungus are most commonly used allergens. Usually, mouse are sensitized with allergen and adjuvant such as aluminum hydroxide gel or Freund adjuvant for 2-3 weeks (once/week) then are challenged with allergen intranasally every day for 1 week. Mouse are sacrificed within 24 hours after final challenge and several parameters of allergic rhinitis are evaluated. They include nasal rubbing and sneezing count, eosinophil count in the nasal mucosa, total and allergen specific immunoglobulin E, nasal cytokine level and splenic cytokine level by splenocyte culture. By revealing those parameters, researchers could identify the allergic status of the mouse. However, there are many variables in mouse model of allergic rhinitis such as mouse strain, type of allergen, sensitization time, adjuvant, acute or chronic type, and allergen administration route etc. In this review, several variables and protocols of mouse model of AR will be discussed in detail.
참고문헌 (24)
- Gross EA, "Comparative morphometry of the nasal cavity in rats and mice", J Anat, 135(Pt 1), pp.83~88 (1982)
- Wagner JG, "Enhancement of nasal inflammatory and epithelial responses after ozone and allergen coexposure in Brown Norway rats", Toxicol Sci, 67(2), pp.284~294 (2002)
- Coleman RA, "Current animal models are not predictive for clinical asthma", Pulm Pharmacol Ther, 12(2), pp.87~89 (1999)
- Finkelman FD, "Usefulness and optimization of mouse models of allergic airway disease", J Allergy Clin Immunol, 121(3), pp.603~606 (2008)
- Kaviratne M, "IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent", J Immunol, 173(6), pp.4020~4029 (2004)
- Eisenbarth SC, "Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen", J Exp Med, 196(12), pp.1645~1651 (2002)
- Williams CM, "Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice", J Exp Med, 192(3), pp.455~462 (2000)
- Mo JH, "The role of hypoxia-inducible factor 1α in allergic rhinitis", Am J Rhinol Allergy, 28(2), pp.e100~e106 (2014)
- Lim YS, "Induction of airway remodeling of nasal mucosa by repetitive allergen challenge in a murine model of allergic rhinitis", Ann Allergy Asthma Immunol, 98(1), pp.22~31 (2007)
- Johnson JR, "Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling", Am J Respir Crit Care Med, 169(3), pp.378~385 (2004)
- Kheradmand F, "A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease", J Immunol, 169(10), pp.5904~5911 (2002)
- Kelada SN, "Strain-dependent genomic factors affect allergen-induced airway hyperresponsiveness in mice", Am J Respir Cell Mol Biol, 45(4), pp.817~824 (2011)
- Sahu N, "Modeling susceptibility versus resistance in allergic airway disease reveals regulation by Tec kinase Itk", PLoS One, 5(6), pp.e11348~ (2010)
- 장윤석, "Influence of the Adjuvants and Genetic Background on the Asthma Model Using Recombinant Der f 2 in Mice", Immune Network, 13(6), pp.295~300 (2013), 대한면역학회
- Yun JB, "House dust mite allergic rhinitis model in C57BL", 6 mice, 2000, pp.43(3), 276~282
- Ryu JH, "Distinct TLR-mediated pathways regulate house dust mite-induced allergic disease in the upper and lower airways", J Allergy Clin Immunol, 131(2), pp.549~561 (2013)
- MacLean JA, "Antigeninduced airway hyperresponsiveness, pulmonary eosinophilia, and chemokine expression in B cell-deficient mice", Am J Respir Cell Mol Biol, 20(3), pp.379~387 (1999)
- Oettgen HC, "Active anaphylaxis in IgE-deficient mice", Nature, 370(6488), pp.367~370 (1994)
- Mehlhop PD, "Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma", Proc Natl Acad Sci U S A, 94(4), pp.1344~1349 (1997)
- Carr VM, "Tissue-specific effects of allergic rhinitis in mouse nasal epithelia", Chem Senses, 37(7), pp.655~668 (2012)
- Karras JG, "Anti-inflammatory activity of inhaled IL-4 receptor-alpha antisense oligonucleotide in mice", Am J Respir Cell Mol Biol, 36(3), pp.276~285 (2007)
- Gavett SH, "Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice", Am J Physiol, 272(2 Pt 1), pp.L253~L261 (1997)
- Wenzel S, "Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies", Lancet, 370(9596), pp.1422~1431 (2007)
- Wagner JG, "Allergic Rhinitis" (2012), InTech